| This week's sponsor is Premier Research | |  | How to Neutralize the Placebo Effect
Placebo response is a natural enemy of any analgesia trial. While it can help, it can also harm. Learn more about this growing phenomenon by catching the start of our 14-part Placebo Problem blogseries. Premier Research. It's what we do. Best. |
Featured Story | | | Monday, September 18, 2017 Cambridge, Massachusetts-based venture capital group Flagship Pioneering has filed a $500 million offering with the Securities & Exchange Commission to set up a sixth investment fund. |
|
|
| This week's sponsor is Althea. | |  | |
Top Stories Monday, September 18, 2017 It looked like a done deal: Last month, Regenxbio penned a pact to acquire Dimension Therapeutics for the modest sum of $86 million as it looked to add two early-stage gene therapies to its pipeline. Monday, September 18, 2017 The Bill & Melinda Gates Foundation is investing up to $40 million in Immunocore to spur research into the use of T cell receptor-based therapeutics to treat tuberculosis and HIV. Monday, September 18, 2017 For pharma and biotech, in which data is the most valuable asset, industry analysts agree that digital transformation presents an opportunity to realize unprecedented productivity gains and competitive advantage. Monday, September 18, 2017 A phase 3 trial of Nabriva Therapeutics’ antibiotic lefamulin has met its primary endpoint. The drug held its own against established treatment moxifloxacin, raising hopes that Nabriva can establish it as a first-line monotherapy treatment of community-acquired bacterial pneumonia. Monday, September 18, 2017 Upstart Rodin Therapeutics has gained $27 million as it plots clinical work on a new Alzheimer’s candidate next year. Monday, September 18, 2017 HIV can hide in immune cells called CD4 T cells, creating reservoirs that allow the virus to survive and replicate. Researchers at the University of Montreal Hospital Research Centre say they’ve discovered a way to block this replication in the stomach. Monday, September 18, 2017 Teva unveiled terms to sell its remaining women's health products, gaining $1.38 billion that'll go toward paying down debt. Resources Sponsored by: Ashfield Healthcare Join this webinar to learn how to design, deliver, and measure a successful patient support program. Presented by Nareda Mills, Ashfield's SVP of Patient Services in the US, you’ll discover how to improve adherence and improve patient outcomes using 5 key methods. Presented By: PRA Health Sciences Children participating in pediatric clinical trials are included in the contraceptive requirements applied to women of child-bearing potential, creating significant challenges for sponsors, parents, investigators and study staff. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. | 
